An $18 billion offer from three major drug wholesalers aimed at settling litigation over their alleged role in the opioid crisis fell through, after more than 20 state attorneys general rejected it in a letter to the companies’ law firms this week.
The letter, reviewed by The Wall Street Journal, shows that the drug industry hasn’t won enough support from states to begin moving the sprawling litigation to a global resolution.